Volume 7, Issue 3 (7-2019)                   JoMMID 2019, 7(3): 61-65 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Seyed N, Rafati S. Resolution and pro-resolving lipid mediators in Leishmania infection. JoMMID. 2019; 7 (3) :61-65
URL: http://jommid.pasteur.ac.ir/article-1-195-en.html
Department of Immunotherapy and leishmania vaccine research
Abstract:   (1433 Views)
The acute inflammatory response is the body’s natural reaction to inciting stimuli including trauma and pathogens. Well-known pro-inflammatory metabolites take control of this reaction to recruit the leukocytes into the inflamed tissue. These cells professionally ingest and kill the invading pathogens and clear the debris of dead or injured cells. This further signals the tissue regeneration and gain of function, another active process mediated by newly uncovered metabolites. These newly identified metabolites are anti-inflammatory in nature and downregulate the active inflammation. These molecules and their cognate receptors are novel targets for the treatment of chronic inflammatory diseases. Although not very well understood, these mediators are suspected to support intracellular parasite survival (as Leishmania parasite) and are worth further investigation for innovative therapeutic interventions.
Full-Text [PDF 395 kb]   (181 Downloads)    
Type of Study: Review article | Subject: Microbial pathogenesis
Received: 2019/06/15 | Accepted: 2019/06/19 | Published: 2019/11/3

References
1. Rodrigues JC, Godinho JL, de Souza W. Biology of human pathogenic trypanosomatids: epidemiology, lifecycle and ultrastructure. Subcell Biochem. 2014;74:1-42. [DOI:10.1007/978-94-007-7305-9_1]
2. Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. Leishmaniasis: a review. F1000Res. 2017;6:750. [DOI:10.12688/f1000research.11120.1]
3. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7(9):581-96. [DOI:10.1016/S1473-3099(07)70209-8]
4. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007;5(11):873-82. [DOI:10.1038/nrmicro1748]
5. Faria DR, Gollob KJ, Barbosa J, Jr., Schriefer A, Machado PR, Lessa H, et al. Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun. 2005;73(12):7853-9. [DOI:10.1128/IAI.73.12.7853-7859.2005]
6. Convit J, Kerdel-Vegas F, Gordon B. Disseminated anergic cutaneous leishmaniasis. Br J Dermatol. 1962;74:132-5. [DOI:10.1111/j.1365-2133.1962.tb13475.x]
7. Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis. 2003;3(2):87-98. [DOI:10.1016/S1473-3099(03)00517-6]
8. Ribeiro-Gomes FL, Sacks D. The influence of early neutrophil-Leishmania interactions on the host immune response to infection. Front Cell Infect Microbiol. 2012;2:59. [DOI:10.3389/fcimb.2012.00059]
9. Peters NC, Kimblin N, Secundino N, Kamhawi S, Lawyer P, Sacks DL. Vector transmission of leishmania abrogates vaccine-induced protective immunity. PLoS Pathog. 2009;5(6):e1000484. [DOI:10.1371/journal.ppat.1000484]
10. Abdeladhim M, Kamhawi S, Valenzuela JG. What's behind a sand fly bite? The profound effect of sand fly saliva on host hemostasis, inflammation and immunity. Infect Genet Evol. 2014;28:691-703. [DOI:10.1016/j.meegid.2014.07.028]
11. Peters NC, Egen JG, Secundino N, Debrabant A, Kimblin N, Kamhawi S, et al. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science. 2008;321(5891):970-4. [DOI:10.1126/science.1159194]
12. Peters NC, Sacks DL. The impact of vector-mediated neutrophil recruitment on cutaneous leishmaniasis. Cell Microbiol. 2009;11(9):1290-6. [DOI:10.1111/j.1462-5822.2009.01348.x]
13. Valenzuela JG, Belkaid Y, Garfield MK, Mendez S, Kamhawi S, Rowton ED, et al. Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein. J Exp Med. 2001;194(3):331-42. [DOI:10.1084/jem.194.3.331]
14. Rogers M, Kropf P, Choi BS, Dillon R, Podinovskaia M, Bates P, et al. Proteophosophoglycans regurgitated by Leishmania-infected sand flies target the L-arginine metabolism of host macrophages to promote parasite survival. PLoS Pathog. 2009;5(8):e1000555. [DOI:10.1371/journal.ppat.1000555]
15. Laufs H, Muller K, Fleischer J, Reiling N, Jahnke N, Jensenius JC, et al. Intracellular survival of Leishmania major in neutrophil granulocytes after uptake in the absence of heat-labile serum factors. Infect Immun. 2002;70(2):826-35. [DOI:10.1128/IAI.70.2.826-835.2002]
16. Carlsen ED, Hay C, Henard CA, Popov V, Garg NJ, Soong L. Leishmania amazonensis amastigotes trigger neutrophil activation but resist neutrophil microbicidal mechanisms. Infect Immun. 2013;81(11):3966-74. [DOI:10.1128/IAI.00770-13]
17. Laskay T, van Zandbergen G, Solbach W. Neutrophil granulocytes as host cells and transport vehicles for intracellular pathogens: apoptosis as infection-promoting factor. Immunobiology. 2008;213(3-4):183-91. [DOI:10.1016/j.imbio.2007.11.010]
18. Mukhopadhyay D, Mukherjee S, Roy S, Dalton JE, Kundu S, Sarkar A, et al. M2 Polarization of Monocytes-Macrophages Is a Hallmark of Indian Post Kala-Azar Dermal Leishmaniasis. PLoS Negl Trop Dis. 2015;9(10):e0004145. [DOI:10.1371/journal.pntd.0004145]
19. Tomiotto-Pellissier F, Bortoleti B, Assolini JP, Goncalves MD, Carloto ACM, Miranda-Sapla MM, et al. Macrophage Polarization in Leishmaniasis: Broadening Horizons. Front Immunol. 2018;9:2529. [DOI:10.3389/fimmu.2018.02529]
20. Gilroy D, De Maeyer R. New insights into the resolution of inflammation. Semin Immunol. 2015;27(3):161-8. [DOI:10.1016/j.smim.2015.05.003]
21. Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest. 2018;128(7):2657-69. [DOI:10.1172/JCI97943]
22. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92-101. [DOI:10.1038/nature13479]
23. Serhan CN, Chiang N, Dalli J. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration. Mol Aspects Med. 2018;64:1-17. [DOI:10.1016/j.mam.2017.08.002]
24. El Kebir D, Filep JG. Role of neutrophil apoptosis in the resolution of inflammation. ScientificWorldJournal. 2010;10:1731-48. [DOI:10.1100/tsw.2010.169]
25. Jones HR, Robb CT, Perretti M, Rossi AG. The role of neutrophils in inflammation resolution. Semin Immunol. 2016;28(2):137-45. [DOI:10.1016/j.smim.2016.03.007]
26. Truman LA, Ford CA, Pasikowska M, Pound JD, Wilkinson SJ, Dumitriu IE, et al. CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood. 2008;112(13):5026-36. [DOI:10.1182/blood-2008-06-162404]
27. Ravichandran KS. Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways. Immunity. 2011;35(4):445-55. [DOI:10.1016/j.immuni.2011.09.004]
28. Fox S, Leitch AE, Duffin R, Haslett C, Rossi AG. Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease. J Innate Immun. 2010;2(3):216-27. [DOI:10.1159/000284367]
29. El Kebir D, Jozsef L, Pan W, Wang L, Petasis NA, Serhan CN, et al. 15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury. Am J Respir Crit Care Med. 2009;180(4):311-9. [DOI:10.1164/rccm.200810-1601OC]
30. Greenlee-Wacker MC. Clearance of apoptotic neutrophils and resolution of inflammation. Immunol Rev. 2016;273(1):357-70. [DOI:10.1111/imr.12453]
31. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol. 2005;6(12):1191-7. [DOI:10.1038/ni1276]
32. Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, Brady HR. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol. 2000;164(4):1663-7. [DOI:10.4049/jimmunol.164.4.1663]
33. Lopez-Munoz RA, Molina-Berrios A, Campos-Estrada C, Abarca-Sanhueza P, Urrutia-Llancaqueo L, Pena-Espinoza M, et al. Inflammatory and Pro-resolving Lipids in Trypanosomatid Infections: A Key to Understanding Parasite Control. Front Microbiol. 2018;9:1961. [DOI:10.3389/fmicb.2018.01961]
34. Chang HY, Lee HN, Kim W, Surh YJ. Docosahexaenoic acid induces M2 macrophage polarization through peroxisome proliferator-activated receptor gamma activation. Life Sci. 2015;120:39-47. [DOI:10.1016/j.lfs.2014.10.014]
35. Kang JW, Lee SM. Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis. Biochim Biophys Acta. 2016;1861(9 Pt A):1025-35. [DOI:10.1016/j.bbalip.2016.06.002]
36. Newson J, Stables M, Karra E, Arce-Vargas F, Quezada S, Motwani M, et al. Resolution of acute inflammation bridges the gap between innate and adaptive immunity. Blood. 2014;124(11):1748-64. [DOI:10.1182/blood-2014-03-562710]
37. Fullerton JN, Gilroy DW. Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov. 2016;15(8):551-67. [DOI:10.1038/nrd.2016.39]
38. Kohli P, Levy BD. Resolvins and protectins: mediating solutions to inflammation. Br J Pharmacol. 2009;158(4):960-71. [DOI:10.1111/j.1476-5381.2009.00290.x]
39. Mendonca MG, de Brito ME, Rodrigues EH, Bandeira V, Jardim ML, Abath FG. Persistence of leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure? J Infect Dis. 2004;189(6):1018-23. [DOI:10.1086/382135]
40. Serezani CH, Perrela JH, Russo M, Peters-Golden M, Jancar S. Leukotrienes are essential for the control of Leishmania amazonensis infection and contribute to strain variation in susceptibility. J Immunol. 2006;177(5):3201-8. [DOI:10.4049/jimmunol.177.5.3201]
41. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med. 2000;192(8):1197-204. [DOI:10.1084/jem.192.8.1197]
42. Wenzel A, Van Zandbergen G. Lipoxin A4 receptor dependent leishmania infection. Autoimmunity. 2009;42(4):331-3. [DOI:10.1080/08916930902828239]
43. Plagge M, Laskay T. Early Production of the Neutrophil-Derived Lipid Mediators LTB4 and LXA4 Is Modulated by Intracellular Infection with Leishmania major. Biomed Res Int. 2017;2017:2014583. [DOI:10.1155/2017/2014583]
44. Paloque L, Perez-Berezo T, Abot A, Dalloux-Chioccioli J, Bourgeade-Delmas S, Le Faouder P, et al. Polyunsaturated fatty acid metabolites: biosynthesis in Leishmania and role in parasite/host interaction. J Lipid Res. 2019;60(3):636-47. [DOI:10.1194/jlr.M091736]
45. Wei F, Gong W, Wang J, Yang Y, Liu J, Wang Y, et al. Role of the lipoxin A4 receptor in the development of neutrophil extracellular traps in Leishmania infantum infection. Parasit Vectors. 2019;12(1):275. [DOI:10.1186/s13071-019-3530-8]
46. Guimaraes-Costa AB, DeSouza-Vieira TS, Paletta-Silva R, Freitas-Mesquita AL, Meyer-Fernandes JR, Saraiva EM. 3'-nucleotidase/nuclease activity allows Leishmania parasites to escape killing by neutrophil extracellular traps. Infect Immun. 2014;82(4):1732-40. [DOI:10.1128/IAI.01232-13]
47. Colas RA, Ashton AW, Mukherjee S, Dalli J, Akide-Ndunge OB, Huang H, et al. Trypanosoma cruzi Produces the Specialized Proresolving Mediators Resolvin D1, Resolvin D5, and Resolvin E2. Infect Immun. 2018;86(4). [DOI:10.1128/IAI.00688-17]
48. Malta-Santos H, Andrade BB, Zanette DL, Costa JM, Bozza PT, Bandeira-Melo C, et al. Resolvin D1 drives establishment of Leishmania amazonensis infection. Sci Rep. 2017;7:46363. [DOI:10.1038/srep46363]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.